Home

Investor Relations

TSX:LEAF: 16.03
0.06 0.37% Volume: 379,256 Pricing delayed 20 minutes December 12, 2017

Company Overview

MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.

Latest News

4 Dec 2017.
/THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ./ MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") is pleased to announce that it has completed its previously announced offering (the "Offering"), on a "bought deal" basis, pursuant to a short form prospectus, of an aggregate of 6,072,600 common shares of the Company (the "Offered Shares") at a price of $16.55 per Offered Share (the "Offering Price"). The Company offered and sold a total of 3,625,470 Offered Shares (the "Treasury Offering"), and an aggregate of 2,447,130 Offered Shares were offered and sold by certain selling shareholders of the Company (the "Secondary Offering"), namely: Zola Finance Inc., Rayray Investments Inc., Baronford Capital Corporation, AJA Holdings 2013 Inc. and MENA Investment Network Inc. (collectively, the "Selling Shareholders"), resulting in aggregate gross proceeds of ...
1 Dec 2017.
MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified producer of medical cannabis, is proud to announce that it won a total of 10 prestigious awards – more than any other LP – at the 2017 edition of the Canadian Cannabis Awards including Top Licensed Producer. In addition to Top LP, MedReleaf won a number of other categories including: Top Indica Flower , Sedamen

Top High CBD Flower, Avidekel

Top High THC Flower, Eran Almog

Top High CBD Oil, Avidekel "I am incredibly proud of our showing at the Canadian Cannabis Awards this year. Taking top spot in four categories, in addition to Top LP , is a testament to the hard work of every single member of the MedReleaf team and the support of our loyal patient base," noted Neil Closner , CEO of MedReleaf . MedReleaf rounded out its total of 10 awards with second place finishes in top customer service, packaging, compassionate pricing and top ...
14 Nov 2017.
MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP certified producer of medical cannabis, today announced that its Australian joint venture partner, Indica Industries Pty Ltd. (t/a "MedReleaf Australia"), has been granted a licence from the Australian Government Office of Drug Control ("ODC") for the cultivation and production of medical cannabis. The licence to undertake authorized cannabis activities commences on November 10, 2018 in order to allow time to complete infrastructure development of the facility. "We're focused on international expansion in countries with a federal legal framework for cannabis, and Australia is an attractive market with a population about two thirds the size of Canada and a focus on medicinal applications," said Neil Closner, CEO of MedReleaf.  "Providing our expertise to local partners allows us to participate in a greater number of international markets in a capital efficient way." MedReleaf , ...